Skip to content

BD Diagnostics

Country not established

Devices
2

What BD Diagnostics makes

Bd Diagnostics manufactures automated cytology screening systems, including the PAPNET® Testing System for automated Pap smear analysis and the AUTOPAP® 300 QC system for automated Pap smear screening and quality control.

These devices are classified as Class III under FDA regulations and are listed under the Premarket Approval (PMA) pathway. The company is based in the United States.

AI-generated from registry data, 20 Sep 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

Frequently asked questions

How many devices does Bd Diagnostics have in the registry?

The registry currently lists 2 devices for Bd Diagnostics. Devices recorded under merged duplicate company entries are counted once.

Which registries list Bd Diagnostics's devices?

Among its 2 most recently registered devices, Bd Diagnostics has devices listed in FDA PMA (2 devices).

What risk classes do Bd Diagnostics's devices fall under?

Among its 2 most recently registered devices, the classes recorded for Bd Diagnostics's devices are Class III. Each device page shows its own class and authorisation.

What are the newest devices from Bd Diagnostics in the registry?

The most recently registered devices listed for Bd Diagnostics include PAPNET (R) TESTING SYSTEM and AUTOPAP(R) 300 QC AUTOMATIC PAP SCREENER/QC SYSTEM.

Generated automatically from registry data and not verified by a human reviewer.